BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22967413)

  • 1. [Clinical significance of the Wilms' tumor 1 mRNA expression in childhood myelodysplastic syndrome].
    Cheng YF; Zhang LP; Liu YR; Qin YZ; Wu J; Liu GL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):536-40. PubMed ID: 22967413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
    Yang JK; Li JL; Li ZG; Li ZG; Liu PJ; Li JY; Lü HR; Deng Q; Lin XM; Cao JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.
    Iwasaki T; Sugisaki C; Nagata K; Takagi K; Takagi A; Kojima T; Ito M; Nakamura S; Naoe T; Murate T
    Pathol Int; 2007 Oct; 57(10):645-51. PubMed ID: 17803653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
    Zuo Y; Cheng Y; Zhang L; Qin Y; Luo H
    Hematology; 2019 Dec; 24(1):480-486. PubMed ID: 31210595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
    Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.
    Kramarzova K; Stuchly J; Willasch A; Gruhn B; Schwarz J; Cermak J; Machova-Polakova K; Fuchs O; Stary J; Trka J; Boublikova L
    Leukemia; 2012 Sep; 26(9):2086-95. PubMed ID: 22430637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
    Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
    Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
    Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
    Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of WT1 gene in patients with myelodysplastic syndrome and acute leukemia].
    Lu Y; Jin J; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):464-6. PubMed ID: 15363132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
    Tamura H; Dan K; Yokose N; Iwakiri R; Ohta M; Sakamaki H; Tohyama K; Kondo A; Hyodo H; Nakamura K; Yamashita T; Elisseeva OA; Oka Y; Oji Y; Sugiyama H; Ogata K
    Leuk Res; 2010 Aug; 34(8):986-90. PubMed ID: 20031209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
    de Vries AC; Langerak AW; Verhaaf B; Niemeyer CM; Stary J; Schmiegelow K; van Wering ER; Zwaan CM; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leukemia; 2008 Jun; 22(6):1170-4. PubMed ID: 18323803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 gene expression lowered by IL-12 In vitro in peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes.
    Pan L; Zhang XJ; Niu ZY; Suo XH; Zhang JY; Yang L; Liu XJ; Qiao SK; Dong ZR; Ohno R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):501-7. PubMed ID: 16800930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Wilms' Tumor 1 Gene in Bone Marrow of Patients with Myelodysplastic Syndrome and Its Clinical Significance].
    Pan DQ; Zhao WS; Yin CX; He H; Lin R; Zhao K; Ye JY; Liu QF; Dai M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1501-1507. PubMed ID: 36208256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
    Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
    Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WT1 gene expression in myelodysplastic syndrome and its clinical implication].
    Huang J; Jin J; Xu WL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):132-5. PubMed ID: 16610077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparisons of clinical features of chronic aplastic anemia and myelodysplastic syndrome in children].
    Hao JJ; Qiu YN; Zhou DF; Xiao Y; Liu Q; Jin RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):867-9. PubMed ID: 22099192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.